Literature DB >> 12428756

Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Zhen Yan1.   

Abstract

Serotonergic neurotransmission in prefrontal cortex (PFC) plays a key role in regulating emotion and cognition under normal and pathological conditios. Increasing evidence suggests that serotonin receptors are involved in the complex regulation of GABAergic inhibitory transmission in PFC. Activation of postsynaptic 5-HT2 receptors in PFC pyramidal neurons inhibits GABAA-receptor currents via phosphorylation of GABAA receptor gamma2 subunits by RACK1-anchored PKC. In contrast, activation of postsynaptic 5-HT4 receptors produces an activity-dependent bi-directional regulation of GABA-evoked currents in PFC pyramidal neurons, which is mediated through phosphorylation of GABAA-receptor beta subunits by anchored PKA. On the presynaptic side, GABAergic inhibition is regulated by 5-HT through the activation of 5-HT2, 5-HT1, and 5-HT3 receptors on GABAergic intereneurons. These data provide a molecular and cellular mechanism for serotonin to dynamically regulate synaptic transmission and neuronal excitability in the PFC network, which may underlie the actions of many antidepressant and antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12428756     DOI: 10.1385/MN:26:2-3:203

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  106 in total

Review 1.  The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

Authors:  R A Bantick; J F Deakin; P M Grasby
Journal:  J Psychopharmacol       Date:  2001-03       Impact factor: 4.153

Review 2.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

Review 3.  Anchoring proteins for protein kinase C: a means for isozyme selectivity.

Authors:  D Mochly-Rosen; A S Gordon
Journal:  FASEB J       Date:  1998-01       Impact factor: 5.191

4.  Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

Authors:  N Ropert; N Guy
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

5.  GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.

Authors:  D A Lewis
Journal:  Brain Res Brain Res Rev       Date:  2000-03

6.  Overlap of dopaminergic, adrenergic, and serotoninergic receptors and complementarity of their subtypes in primate prefrontal cortex.

Authors:  P S Goldman-Rakic; M S Lidow; D W Gallager
Journal:  J Neurosci       Date:  1990-07       Impact factor: 6.167

7.  C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo.

Authors:  D Ron; J Luo; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

Review 8.  The pharmacology of the 5-HT4 receptor.

Authors:  B Costall; R J Naylor
Journal:  Int Clin Psychopharmacol       Date:  1993-11       Impact factor: 1.659

9.  Function of the alpha 1 beta 2 gamma 2S gamma-aminobutyric acid type A receptor is modulated by protein kinase C via multiple phosphorylation sites.

Authors:  S Kellenberger; P Malherbe; E Sigel
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

Review 10.  The role of serotonin in panic, anxiety and depression.

Authors:  J F Deakin
Journal:  Int Clin Psychopharmacol       Date:  1998-04       Impact factor: 1.659

View more
  27 in total

1.  Inhibition by 5-HT of the synaptic responses evoked by callosal fibers on cortical neurons in the mouse.

Authors:  José A Troca-Marín; Emilio Geijo-Barrientos
Journal:  Pflugers Arch       Date:  2010-09-14       Impact factor: 3.657

2.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

3.  Different serotonin receptor agonists have distinct effects on sound-evoked responses in inferior colliculus.

Authors:  Laura M Hurley
Journal:  J Neurophysiol       Date:  2006-07-26       Impact factor: 2.714

4.  Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning.

Authors:  Alexander Barre; Coralie Berthoux; Dimitri De Bundel; Emmanuel Valjent; Joël Bockaert; Philippe Marin; Carine Bécamel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

5.  cAMP-dependent protein kinase inhibits α7 nicotinic receptor activity in layer 1 cortical interneurons through activation of D1/D5 dopamine receptors.

Authors:  Pragya Komal; Jasem Estakhr; Melad Kamran; Anthony Renda; Raad Nashmi
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

6.  The role of glutamatergic and GABAergic systems on serotonin- induced feeding behavior in chicken.

Authors:  Sepideh Seyedali Mortezaei; Morteza Zendehdel; Vahab Babapour; Keyvan Hasani
Journal:  Vet Res Commun       Date:  2013-09-05       Impact factor: 2.459

7.  5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia.

Authors:  O Dergacheva; H Kamendi; X Wang; R A Pinol; J Frank; C Gorini; H Jameson; M R Lovett-Barr; D Mendelowitz
Journal:  Neuroscience       Date:  2009-09-20       Impact factor: 3.590

8.  Activation of raphe efferents to the medial prefrontal cortex by corticotropin-releasing factor: correlation with anxiety-like behavior.

Authors:  Edward G Meloni; Catherine L Reedy; Bruce M Cohen; William A Carlezon
Journal:  Biol Psychiatry       Date:  2007-12-03       Impact factor: 13.382

9.  Activation of the serotonin 1A receptor alters the temporal characteristics of auditory responses in the inferior colliculus.

Authors:  Laura M Hurley
Journal:  Brain Res       Date:  2007-09-04       Impact factor: 3.252

10.  The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression.

Authors:  Esra Küçükibrahimoğlu; Melek Z Saygin; Mecit Calişkan; Okan K Kaplan; Cüneyt Unsal; M Zafer Gören
Journal:  Eur J Clin Pharmacol       Date:  2009-04-17       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.